U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Morbidity and Mortality Weekly Report (MMWR)

CDC Stacks Public Health Publications

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

(16)
(66)
(183)
(226)
(498)
(673)
(659)
(403)
(489)
(557)
(246)
(325)
(419)
(393)
(80)
(145)
(99)
(110)
(97)
(92)
(118)
(92)
(108)
(96)
(97)
(92)
(79)
(97)
(87)
(91)
(88)
(76)
(74)
(84)
(80)
(69)
(70)
(73)
(68)
(69)
(59)
(67)
(62)
(64)
(62)
(66)
(72)
(55)
(53)
(55)
(60)
(56)
(58)
(54)
(53)
(56)
(55)
(52)
(54)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(51)
0 of 75
(2)
(1)
(388)
(2)
(8)
(2968)
(5)
(2049)
(13)
(48)
(85)
(5)
(1)
(1)
(2)
(19)
(13)
(1)
(69)
(3574)
(3)
(4)
0 of 22
(1)
(2)
(15)
(33)
(13)
(1)
(8)
(2)
(2)
(4)
(5)
(25)
(1)
(7)
(2)
(180)
(1)
(112)
(2)
(3)
(7)
(1)
(3)
(10)
(11)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(167)
(159)
(1)
(1)
(1)
(1)
(20)
(1)
(28)
(1)
(2)
(22)
(2)
(1)
(1)
(1)
(1)
(1)
(23)
(8)
(1)
(2)
(3)
(1)
(6)
(1)
(19)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(12)
(1)
(1)
(1)
(2)
(1)
(16)
(1)
(1)
(4)
(1)
(20)
(1)
(5)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(2)
(2)
(1)
(863)
(2)
(1)
(11)
(1)
(3)
(7)
(1)
(1)
(1)
(87)
(4)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(2)
(1)
(1)
(14)
(3)
(53)
(1)
(4)
(1)
(1)
(1)
(8)
(16)
(1)
(1)
(1)
(1)
(7)
(1)
(8)
(263)
(1)
(7)
(1)
(1)
(3)
(199)
(2)
(2)
(1)
(1)
(4)
(2)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(2)
(2)
(39)
(1)
(1)
(12)
(13)
(1)
(5)
(1)
(2)
(11)
(1)
(1)
(169)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(1)
(7)
(1)
(1)
(1)
(4)
(68)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(38)
(2)
(1)
(1)
(5)
(3)
(12)
(316)
(1)
(1)
(1)
(1)
(28)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(434)
(3)
(6)
(42)
(3)
(12)
(5)
(1)
(4)
(10)
(1)
(1)
(20)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(15)
(14)
(8)
(2)
(19)
(1)
(111)
(1)
(1)
(1)
(1)
(4)
(5)
(24)
(1)
(1)
(9)
(3)
(75)
(1)
(304)
(1)
(1)
(1)
(31)
(161)
(12)
(1)
(174)
(3)
(3)
(10)
(7)
(25)
(1)
(1)
(1)
(4)
(23)
(42)
(1)
(1)
(1)
(1)
(111)
(1)
(1)
(1)
(1)
(212)
(19)
(1)
(1)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(1)
(5)
(32)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(13)
(1)
(3)
(96)
(1)
(1)
(2)
(4)
(5)
(209)
(1)
(2)
(3)
(1)
(1)
(125)
(10)
(7)
(3)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(200)
(1)
(1)
(269)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(55)
(1)
(1)
(1)
(1)
(1)
(5)
(264)
(12)
(5)
(3)
(11)
(1)
(8)
(3)
(1)
(1)
(1)
(3)
(1)
(304)
(3)
(1)
(131)
(2)
(1)
(164)
(1)
(1)
(1)
(77)
(4)
(3)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(2)
(1)
(4)
(1)
(2)
(3)
(3)
(113)
(1)
(1)
(9)
(2)
(27)
(34)
(2)
(1)
(1)
(3)
(1)
(18)
(1)
(5)
(3)
(3)
(60)
(1)
(236)
(2)
(1)
(186)
(2)
(1)
(5)
(1)
(497)
(1)
(6)
(2)
(16)
(1)
(7)
(1)
(5)
(156)
(1)
(1)
(1)
(6)
(3)
(9)
(4)
(31)
(1)
(1)
(4)
(1)
(248)
(1)
(45)
(1)
(2)
(4)
(10)
(8)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(536)
(115)
(1)
(1)
(4)
(10)
(1)
(1)
(266)
(1)
(53)
(78)
(218)
(226)
(295)
(51)
(45)
(47)
(83)
(66)
(1)
(1)
(1)
(1)
(1)
(3)
(6)
(8)
(31)
(8)
(7)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(298)
(1)
(1)
(13)
(10)
(2)
(27)
(1)
(1)
(1)
(1)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(5)
(16)
(1)
(2)
(1)
(153)
(1)
(1)
(1)
(5)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(91)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(5)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(1)
(4)
(1)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(18)
(13)
(1)
(14)
(1)
(1)
(14)
(11)
(1)
(2)
(1)
(116)
(46)
(8)
(2)
(1)
(5)
(9)
(4)
(20)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(2)
(22)
(24)
(1)
(1)
(1)
(3)
(1)
(18)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(183)
(1)
(1)
(476)
(22)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(11)
(8)
(1)
(1)
(1)
(7)
(1)
(1)
(138)
(1)
(22)
(1)
(1)
(67)
(6951)
(1)
(11)
(1)
(1)
(5)
(11)
(151)
(1)
(1)
(11)
(79)
(1)
(1)
(3)
(32)
(3)
(1)
(4)
(215)
(4)
(2)
(1)
(1)
(30)
(2)
(1)
(384)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(240)
(1)
(1)
(192)
(1)
(1)
(2)
(1)
(45)
(1)
(3)
(9)
(6)
(9)
(10)
(1)
0 of 775
(15)
(62)
(187)
(218)
(499)
(662)
(656)
(409)
(483)
(558)
(231)
(311)
(429)
(404)
(81)
(138)
(97)
(104)
(102)
(92)
(119)
(92)
(104)
(97)
(97)
(91)
(80)
(97)
(86)
(90)
(87)
(76)
(75)
(84)
(80)
(69)
(69)
(71)
(69)
(64)
(60)
(68)
(62)
(62)
(62)
(67)
(72)
(56)
(55)
(54)
(59)
(57)
(58)
(54)
(53)
(55)
(55)
(55)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
0 of 75
(1)
(7)
(33)
(71)
(44)
(137)
(157)
(160)
(151)
(137)
(163)
(169)
(155)
(160)
(160)
(156)
(163)
(164)
(156)
(164)
(156)
(171)
(141)
(155)
(158)
(133)
(154)
(140)
(140)
(139)
(136)
(137)
(141)
(130)
(157)
(142)
(135)
(151)
(151)
(175)
(205)
(197)
(164)
(187)
(179)
(200)
(204)
(201)
(221)
(225)
(230)
(219)
(224)
(251)
(252)
(274)
0 of 56
(5)
(2)
(2)
(1)
(4)
(1)
(430)
(106)
(398)
(8472)
0 of 10
(16)
(34)
(1)
(2)
(6)
(1)
0 of 6
(10)
(10)
(25)
(11)
(19)
(26)
(41)
(57)
(19)
(11)
(7)
(36)
(10)
(10)
(50)
(7)
(35)
(1221)
(21)
(1287)
(32)
(73)
(10)
(91)
(26)
(16)
(7)
(784)
(197)
(24)
(127)
(67)
(36)
(61)
(10)
(9)
(11)
(17)
(19)
(38)
(19)
(26)
(15)
(26)
(7)
(11)
(15)
(10)
(7)
(46)
(11)
(8)
(220)
(17)
(17)
(8)
(181)
(138)
(129)
(30)
(8)
(15)
(13)
(9)
(10)
(13)
(15)
(9)
(15)
(8)
(29)
(17)
(10)
(7)
(18)
(100)
(13)
(12)
(35)
(15)
(8)
(12)
(7)
(10)
(11)
(29)
(9)
(9)
(9)
(15)
(20)
(8)
(17)
(7)
(8)
(27)
(73)
(10)
(62)
(7)
(11)
(11)
(13)
(14)
(19)
(79)
(13)
(11)
(14)
(28)
(11)
(12)
(29)
(28)
(12)
(187)
(7)
(7)
(16)
(8)
(18)
(53)
(11)
(7)
(11)
(22)
(20)
(7)
(12)
(10)
(9)
(24)
(12)
(30)
(20)
(29)
(7)
(13)
(12)
(31)
(70)
(10)
(23)
(27)
(11)
(21)
(16)
(7)
(7)
(8)
(13)
(28)
(25)
(9)
(934)
(735)
(8)
(13)
(14)
(35)
(7)
(7)
(102)
(10)
(50)
(7)
(10)
(18)
(11)
(11)
(9)
(58)
(12)
(20)
(14)
(49)
(18)
(19)
(19)
(19)
(7)
(7)
(16)
(177)
(80)
(7)
(2950)
(37)
(12)
(550)
(317)
(243)
(222)
(7)
(24)
(35)
(14)
(17)
(7)
(14)
(12)
(32)
(10)
(79)
(14)
(10)
(8)
(7)
(23)
(8)
(8)
(27)
(448)
(18)
(23)
(15)
(8)
(75)
(26)
(19)
(8)
(18)
(17)
(7)
(17)
(45)
(683)
(8)
(7)
(15)
(59)
(204)
(7)
(10)
(18)
(8)
(12)
(67)
(25)
(14)
(40)
(73)
(8)
(11)
(8)
(8)
(20)
(18)
(22)
(57)
(9)
(8)
(16)
(7)
(28)
(40)
(82)
(7)
(9)
(10)
(7)
(21)
(65)
(8)
(13)
(13)
(27)
(25)
(13)
(10)
(10)
(8)
(166)
(24)
(14)
(36)
(7)
(26)
(9)
(11)
(9)
(23)
(26)
(12)
(91)
(4163)
(626)
(30)
(12)
(17)
(10)
(14)
(8)
(11)
(13)
(7)
(9)
(28)
(15)
(19)
(8)
(8)
(12)
(27)
(17)
(14)
(43)
(20)
(27)
(36)
(10)
(20)
(8)
(19)
(8)
(66)
(7)
(91)
(21)
(9)
(23)
(11)
(15)
(22)
(7)
(8)
(33)
(50)
(66)
(21)
(15)
(149)
(8)
(7)
(12)
(7)
(32)
(16)
(14)
(19)
(18)
(16)
(22)
(10)
(7)
(11)
(7)
(143)
(7)
(44)
(31)
(9)
(41)
(32)
(15)
(650)
(52)
(7)
(26)
(7)
(9)
(56)
(14)
(129)
(18)
(63)
(8)
(10)
(10)
(29)
(10)
(10)
(13)
(19)
(8)
(15)
(23)
(111)
(23)
(1322)
(14)
(10)
(17)
(11)
(13)
(8)
(8)
(47)
(25)
(184)
(12)
(41)
(44)
(24)
(47)
(13)
(13)
(10)
(604)
(394)
(15)
(20)
(14)
(152)
(15)
(52)
(8)
(27)
(10)
(19)
(11)
(101)
(9)
(78)
(9)
(52)
(57)
(57)
(17)
(23)
(60)
(127)
(19)
(96)
(57)
(12)
(39)
(125)
(35)
(94)
(16)
(9)
(10)
(11)
(11)
(51)
(66)
(116)
(29)
(172)
(25)
(17)
(50)
(12)
(10)
(32)
(12)
(10)
(45)
(11)
(8)
(8)
(58)
(31)
(90)
(44)
(17)
(157)
(12)
(31)
(8)
(8)
(9)
(8)
(12)
(28)
(51)
(9)
(204)
(17)
(30)
(16)
(19)
(2426)
(16)
(15)
(18)
(9)
(103)
(20)
(37)
(8)
(205)
(230)
(23)
(8)
(8)
(9)
(18)
(236)
(9)
(49)
(674)
(10)
(304)
(15)
(47)
(58)
(23)
(17)
(8)
(21)
(590)
(13)
(61)
(15)
(14)
(9)
(37)
(26)
(22)
(28)
(188)
(45)
(54)
(48)
(114)
(50)
(8)
(123)
(28)
(11)
(12)
(8)
(32)
(21)
(12)
(22)
(13)
(62)
(16)
(11)
(10)
(70)
(9)
(10)
(8)
(73)
(32)
(113)
(9)
(13)
(40)
(17)
(55)
(17)
(13)
(15)
(18)
(10)
(16)
(37)
(57)
(10)
(11)
(9)
(175)
(17)
(12)
(14)
(1170)
(9)
(9)
(8)
(47)
(9)
(43)
(108)
(9)
(16)
(8)
(19)
(304)
(40)
(33)
(23)
(11)
(12)
(83)
(11)
(12)
(18)
(20)
(8)
(11)
(8)
(19)
(58)
(32)
(82)
(14)
(37)
(8)
(21)
(39)
(13)
(15)
(16)
(9)
(9)
(66)
(19)
(956)
(103)
(15)
(45)
(30)
(15)
(8)
(9)
(53)
(3821)
(9)
(9)
(9)
(31)
(16)
(21)
(16)
(15)
(13)
(16)
(10)
(12)
(9)
(8)
(11)
(18)
(8)
(14)
(14)
(9)
(16)
(38)
(42)
(20)
(10)
(27)
(8)
(12)
(10)
(8)
(249)
(18)
(20)
(8)
(32)
(13)
(113)
(10)
(255)
(594)
(72)
(11)
(21)
(10)
(8)
(11)
(15)
(8)
(10)
(297)
(13)
(8)
(10)
(8)
(14)
(11)
(12)
(11)
(20)
(10)
(9)
(15)
(13)
(13)
(10)
(22)
(10)
(59)
(10)
(9)
(10)
(9)
(9)
(19)
(12)
(9)
(144)
(18)
(14)
(8)
(33)
(144)
(11)
(171)
(10)
(8)
(8)
(22)
(70)
(342)
(114)
(84)
(24)
(36)
(34)
(11)
(30)
(14)
(8)
(10)
(25)
(21)
(29)
(21)
(18)
(16)
(1130)
(17)
(27)
(16)
(18)
(109)
(15)
(21)
(23)
(346)
(10)
(18)
(72)
(16)
(14)
(26)
(14)
(27)
(35)
(10)
(8)
(10)
(204)
(51)
(16)
(20)
(34)
(21)
(10)
(19)
(74)
(19)
(9)
(233)
(965)
(19)
(24)
(67)
(101)
(2516)
(10)
(104)
(12)
(23)
(15)
(16)
(14)
(93)
(179)
(38)
(278)
(15)
(8)
(9)
(13)
(44)
(28)
(91)
(9)
(17)
(18)
(20)
(23)
(71)
(37)
(18)
(12)
(8)
(12)
(21)
(10)
(28)
(10)
(10)
(8)
(21)
(98)
(181)
(28)
(26)
(25)
(10)
(20)
(9)
(57)
(64)
(183)
(291)
(8)
(14)
(11)
(21)
(12)
(8)
(57)
(16)
(34)
(9)
(38)
(593)
(30)
(31)
(146)
(240)
(12)
(176)
(10)
(18)
(10)
(118)
(8)
(11)
(125)
(8)
(16)
(17)
(15)
(18)
(11)
(9)
(18)
(10)
(28)
(35)
(37)
(11)
(8)
(64)
(21)
(16)
(37)
(27)
(10)
(14)
(10)
(14)
(12)
(80)
(31)
(8)
(39)
(9)
(20)
(17)
(12)
(184)
(9)
(28)
(19)
(69)
(23)
(22)
(25)
(14)
(8)
(9)
(108)
(17)
(16)
(41)
(16)
(134)
(51)
(10)
(19)
(10)
(56)
(9)
(8)
(12)
(14)
(92)
(34)
(31)
(11)
(47)
(39)
(86)
(9)
(22)
(14)
(182)
(10)
(8)
(8)
(18)
(32)
(20)
(20)
(12)
(69)
(8)
(8)
(54)
(15)
(11)
(8)
(15)
(8)
(10)
(60)
(18)
(180)
(28)
(35)
(22)
(106)
(19)
(155)
(13)
(9)
(12)
(15)
(68)
(9)
(14)
(182)
(10)
(10)
(19)
(73)
(17)
(28)
(17)
(50)
(17)
(19)
(14)
(460)
(11)
(48)
(48)
(102)
(17)
(100)
(29)
(24)
(32)
(21)
(40)
(10)
(24)
(31)
(20)
(35)
(21)
(12)
(18)
(8)
(42)
(81)
(21)
(26)
(9)
(21)
(9)
(12)
(39)
(14)
(14)
(59)
(11)
(9)
(37)
(17)
(14)
(39)
(14)
(73)
(8)
(10)
(41)
(13)
(14)
(46)
(27)
(755)
(30)
(57)
(10)
(12)
(21)
0 of 1000
(12)
(12)
(15)
(7)
(23)
(9)
(7)
(20)
(8)
(7)
(11)
(14)
(7)
(9)
(7)
(10)
(9)
(12)
(11)
(19)
(9)
(11)
(9)
(10)
(27)
(8)
(9)
(16)
(23)
(15)
(11)
(7)
(7)
(7)
(9)
(13)
(11)
(10)
(15)
(7)
(7)
(10)
(7)
(7)
(7)
(9)
(8)
(19)
(9)
(9)
(7)
(7)
(13)
(7)
(7)
(9)
(7)
(9)
(7)
(16)
(13)
(7)
(12)
(13)
(22)
(28)
(15)
(8)
(8)
(13)
(7)
(19)
(12)
(12)
(13)
(15)
(17)
(9)
(10)
(7)
(11)
(27)
(7)
(13)
(28)
(7)
(10)
(11)
(11)
(13)
(10)
(8)
(18)
(9)
(10)
(16)
(29)
(11)
(12)
(12)
(13)
(8)
(9)
(7)
(28)
(9)
(16)
(8)
(31)
(7)
(7)
(8)
(8)
(11)
(16)
(16)
(12)
(35)
(8)
(11)
(16)
(18)
(9)
(29)
(9)
(16)
(22)
(31)
(10)
(7)
(7)
(10)
(7)
(18)
(9)
(7)
(9)
(7)
(7)
(7)
(11)
(9)
(23)
(20)
(10)
(7)
(7)
(15)
(10)
(8)
(37)
(8)
(22)
(10)
(16)
(11)
(10)
(24)
(13)
(8)
(11)
(7)
(9)
(11)
(9)
(12)
(21)
(9)
(9)
(7)
(11)
(7)
(15)
(9)
(7)
(9)
(12)
(20)
(12)
(7)
(11)
(8)
(7)
(10)
(10)
(7)
(9)
(24)
(7)
(8)
(10)
(12)
(8)
(13)
(25)
(23)
(7)
(24)
(16)
(9)
(7)
(10)
(10)
(12)
(8)
(13)
(9)
(9)
(10)
(7)
(10)
(7)
(19)
(8)
(9)
(7)
(18)
(17)
(11)
(10)
(12)
(9)
(12)
(7)
(9)
(7)
(9)
(9)
(15)
(8)
(8)
(13)
(28)
(7)
(18)
(9)
(12)
(15)
(7)
(7)
(17)
(17)
(8)
(16)
(7)
(8)
(20)
(7)
(8)
(11)
(12)
(21)
(10)
(11)
(10)
(13)
(9)
(8)
(7)
(12)
(8)
(15)
(9)
(11)
(7)
(17)
(12)
(18)
(18)
(7)
(18)
(24)
(11)
(7)
(7)
(12)
(8)
(20)
(20)
(16)
(11)
(12)
(7)
(8)
(10)
(7)
(14)
(16)
(7)
(9)
(11)
(20)
(15)
(9)
(16)
(48)
(9)
(11)
(24)
(10)
(8)
(8)
(7)
(10)
(9)
(7)
(10)
(8)
(53)
(13)
(10)
(11)
(15)
(42)
(16)
(7)
(8)
(8)
(29)
(10)
(8)
(10)
(8)
(8)
(24)
(8)
(11)
(12)
(8)
(13)
(21)
(24)
(10)
(10)
(15)
(20)
(11)
(10)
(15)
(17)
(11)
(18)
(7)
(17)
(16)
(9)
(15)
(18)
(7)
(14)
(16)
(7)
(22)
(7)
(9)
(17)
(12)
(15)
(8)
(18)
(20)
(15)
(11)
(29)
(7)
(10)
(23)
(7)
(7)
(28)
(8)
(7)
(26)
(18)
(7)
(12)
(11)
(8)
(36)
(15)
(12)
(7)
(8)
(15)
(16)
(7)
(7)
(9)
(10)
(9)
(17)
(7)
(12)
(12)
(14)
(12)
(16)
(10)
(13)
(8)
(15)
(23)
(8)
(8)
(8)
(13)
(7)
(17)
(9)
(7)
(30)
(12)
(15)
(13)
(9)
(7)
(7)
(9)
(8)
(7)
(7)
(8)
(14)
(9)
(14)
(17)
(7)
(8)
(7)
(10)
(11)
(7)
(16)
(9)
(60)
(12)
(9)
(8)
(7)
(7)
(9)
(7)
(18)
(7)
(10)
(18)
(9)
(16)
(10)
(8)
(26)
(11)
(8)
(9)
(14)
(26)
(23)
(8)
(43)
(11)
(14)
(7)
(15)
(11)
(21)
(7)
(28)
(15)
(10)
(9)
(25)
(18)
(7)
(8)
(8)
(7)
(7)
(18)
(15)
(15)
(11)
(7)
(8)
(7)
(10)
(14)
(9)
(30)
(16)
(7)
(9)
(19)
(18)
(15)
(9)
(7)
(7)
(8)
(13)
(11)
(15)
(17)
(8)
(49)
(7)
(32)
(13)
(10)
(16)
(7)
(23)
(24)
(9)
(10)
(25)
(8)
(20)
(7)
(7)
(13)
(7)
(11)
(9)
(8)
(7)
(8)
(10)
(9)
(8)
(13)
(7)
(7)
(10)
(16)
(14)
(12)
(7)
(10)
(20)
(9)
(15)
(7)
(7)
(11)
(12)
(11)
(13)
(9)
(7)
(19)
(25)
(17)
(8)
(15)
(9)
(9)
(18)
(17)
(8)
(8)
(12)
(7)
(10)
(7)
(9)
(8)
(18)
(18)
(11)
(8)
(34)
(21)
(7)
(18)
(9)
(7)
(10)
(7)
(10)
(9)
(14)
(14)
(10)
(25)
(12)
(7)
(53)
(7)
(7)
(7)
(19)
(8)
(10)
(10)
(7)
(10)
(9)
(8)
(8)
(20)
(13)
(27)
(8)
(8)
(19)
(7)
(19)
(7)
(11)
(8)
(7)
(15)
(7)
(11)
(11)
(28)
(10)
(9)
(7)
(20)
(10)
(14)
(7)
(8)
(9)
(13)
(11)
(10)
(7)
(13)
(9)
(8)
(10)
(8)
(7)
(7)
(10)
(14)
(9)
(39)
(23)
(10)
(8)
(7)
(10)
(11)
(10)
(13)
(15)
(10)
(7)
(17)
(10)
(7)
(7)
(11)
(11)
(12)
(7)
(10)
(18)
(14)
(8)
(10)
(21)
(16)
(15)
(14)
(9)
(15)
(10)
(19)
(24)
(11)
(20)
(21)
(16)
(7)
(7)
(10)
(23)
(7)
(8)
(17)
(7)
(9)
(11)
(7)
(7)
(18)
(8)
(7)
(7)
(9)
(9)
(14)
(10)
(8)
(13)
(9)
(13)
(8)
(18)
(7)
(7)
(27)
(12)
(8)
(15)
(9)
(17)
(8)
(18)
(7)
(26)
(12)
(9)
(11)
(22)
(8)
(10)
(7)
(7)
(13)
(8)
(7)
(8)
(10)
(21)
(15)
(14)
(35)
(18)
(7)
(8)
(21)
(16)
(24)
(23)
(18)
(9)
(19)
(12)
(13)
(25)
(12)
(11)
(19)
(27)
(17)
(10)
(10)
(8)
(13)
(10)
(9)
(16)
(12)
(10)
(18)
(25)
(11)
(15)
(10)
(18)
(25)
(13)
(16)
(9)
(19)
(13)
(27)
(17)
(18)
(8)
(10)
(8)
(10)
(14)
(10)
(13)
(8)
(11)
(17)
(15)
(13)
(14)
(13)
(8)
(33)
(8)
(11)
(10)
(8)
(11)
(12)
(21)
(10)
(9)
(12)
(24)
(8)
(10)
(14)
(8)
(9)
(19)
(11)
(8)
(8)
(11)
(9)
(8)
(11)
(10)
(8)
(8)
(8)
(14)
(12)
(10)
(15)
(9)
(30)
(11)
(11)
(10)
(14)
(23)
(8)
(9)
(13)
(11)
(10)
(8)
(8)
(9)
(20)
(17)
(12)
(10)
(8)
(8)
(18)
(13)
(17)
(11)
(9)
(29)
(10)
(9)
(13)
(11)
(8)
(29)
(13)
(13)
(9)
(11)
(40)
(8)
(10)
(12)
(14)
(9)
(13)
(16)
(9)
(12)
(9)
(8)
(9)
(11)
(8)
(9)
(40)
(10)
(9)
(20)
(17)
(8)
(24)
(13)
(10)
(24)
(8)
(9)
(18)
(20)
(9)
(9)
(8)
(8)
(29)
(15)
(8)
(72)
(9)
(38)
(8)
(23)
(10)
(24)
(9)
(12)
(9)
(8)
(10)
(12)
(14)
(8)
(22)
(9)
(13)
(10)
(16)
(8)
(9)
(13)
(17)
(11)
(8)
(11)
(15)
(9)
(9)
(13)
(9)
(8)
(20)
(14)
(32)
(9)
(17)
(9)
(10)
(10)
(14)
(8)
(9)
(32)
(16)
(8)
(10)
(8)
(11)
(13)
(15)
(21)
(10)
(15)
(8)
(9)
(12)
(8)
(15)
(12)
(18)
(9)
(12)
(13)
(13)
(23)
(11)
(15)
(11)
(9)
(8)
(8)
(13)
(25)
(13)
(17)
(8)
(13)
(11)
(13)
(11)
(9)
(10)
(8)
(10)
(13)
(21)
(13)
(20)
(23)
(25)
(8)
(9)
(11)
(12)
(15)
(10)
(14)
(10)
(9)
(19)
(14)
(10)
0 of 1000
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(1)
(7)
(1)
(16)
(14)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(34)
(1)
(2)
(106)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(2)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(3)
(1)
(1)
(2)
(68)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(8)
(4)
(1)
(3)
(6)
(5)
(2)
(1)
(11)
(1)
(2)
(3)
(1)
(7)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(6)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(14)
(1)
(3)
(1)
(1)
(3)
(1)
(1)
(92)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3916)
(1)
(1)
(2)
(11)
(10)
(1)
(1)
(41)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(14)
(1)
(1)
(1)
(4)
(20)
(1)
(7)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(13)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(65)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(33)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(21)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(426)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(6)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(5)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(2)
(5)
(1)
(2)
(3)
(2)
(3)
(9)
(2)
(2)
(2)
(2)
(9)
(2)
(7)
(4)
(2)
(2)
(5)
(2)
(12)
(12)
(2)
(7)
(4)
(2)
(3)
(2)
(3)
(4)
(4)
(2)
(5)
(7)
(4)
(2)
(5)
(7)
(2)
(9)
(2)
(2)
(8)
(2)
(2)
(2)
(4)
(9)
(3)
(3)
(2)
(2)
(5)
(9)
(4)
(4)
(2)
(2)
(5)
(4)
(2)
(3)
(3)
(9)
(4)
(4)
(6)
(4)
(2)
(3)
(2)
(6)
(2)
(11)
(2)
(2)
(2)
(3)
(2)
(2)
(2)
(3)
(10)
(4)
(2)
(8)
(2)
(15)
(2)
(2)
(20)
(2)
(3)
(6)
(2)
(2)
(5)
(2)
(13)
(11)
(2)
(30)
(2)
(3)
(3)
(7)
(2)
(3)
(3)
(2)
(2)
(9)
(2)
(14)
(2)
(7)
(3)
(4)
(3)
(2)
(2)
(3)
(9)
(5)
(9)
(52)
(8)
(3)
(13)
(3)
(3)
(2)
(4)
(3)
(9)
(5)
(3)
(2)
(15)
(9)
(5)
(4)
(2)
(5)
(4)
(5)
(4)
(5)
(5)
(11)
(4)
(12)
(5)
(2)
(2)
(12)
(5)
(2)
(3)
(2)
(6)
(2)
(3)
(2)
(3)
(2)
(2)
(415)
(2)
(4)
(7)
(2)
(2)
(2)
(3)
(3)
(3)
(3)
(2)
(6)
(2)
(2)
(3)
(3)
(10)
(2)
(19)
(2)
(7)
(9)
(6)
(4)
(7)
(5)
(4)
(11)
(3)
(2)
(4)
(2)
(13)
(17)
(2)
(25)
(2)
(2)
(4)
(8)
(5)
(12)
(8)
(5)
(3)
(13)
(4)
(17)
(6)
(9)
(2)
(25)
(2)
(2)
(6)
(3)
(9)
(3)
(2)
(4)
(15)
(3)
(4)
(3)
(7)
(16)
(6)
(2)
(27)
(2)
(2)
(4)
(5)
(5)
(24)
(2)
(4)
(2)
(7)
(3)
(9)
(3)
(2)
(9)
(6)
(11)
(5)
(15)
(4)
(2)
(3)
(5)
(6)
(2)
(2)
(118)
(5)
(18)
(3)
(2)
(7)
(129)
(2)
(3)
(2)
(6)
(2)
(2)
(8)
(2)
(2)
(3)
(2)
(4)
(6)
(6)
(3)
(3)
(2)
(3)
(2)
(10)
(12)
(4)
(2)
(3)
(3)
(4)
(9)
(2)
(2)
(2)
(5)
(6)
(4)
(2)
(2)
(13)
(2)
(4)
(2)
(2)
(2)
(4)
(3)
(9)
(2)
(4)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(4)
(3)
(3)
(3)
(4)
(12)
(4)
(2)
(5)
(6)
(5)
(2)
(3)
(14)
(4)
(2)
(2)
(2)
(2)
(2)
(14)
(7)
(7)
(3)
(2)
(3)
(2)
(2)
(2)
(44)
(183)
(2)
(88)
(115)
(2)
(8)
(16)
(10)
(5)
(2)
(14)
(180)
(2)
(4)
(3)
(6)
(93)
(2)
(2)
(2)
(4)
(317)
(7)
(11)
(2)
(6)
(8)
(2)
(3)
(26)
(80)
(2)
(2)
(22)
(3)
(2)
(36)
(30)
(10)
(4)
(3)
(6)
(2)
(3)
(4)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(4)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(2)
(5)
(2)
(2)
(4)
(2)
(2)
(2)
(4)
(15)
(3)
(3)
(2)
(14)
(2)
(2)
(6)
(15)
(13)
(4)
(2)
(3)
(5)
(2)
(2)
(5)
(8)
(2)
(4)
(2)
(3)
(3)
(7)
(2)
(2)
(4)
(4)
(2)
(4)
(2)
(2)
(2)
(2)
0 of 1000
(1)
(53)
(11)
(2)
(2)
(25)
(11)
(2)
(4)
(2)
(3)
(1)
(5)
(32)
(1)
(3)
(6)
(14)
(65)
(12)
(1)
(2)
(4)
(1)
(681)
(2689)
(5)
(38)
(1)
(2)
(1)
(7)
(3)
(15)
(33)
(108)
(2)
(385)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1809)
(1)
(5)
(1)
(8)
(363)
(4)
(3)
(50)
(3)
0 of 55
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(4)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
0 of 737
(81)
(1)
(6)
0 of 3
Showing 261 - 280 of 9447 results
  • MMWR Morbidity and Mortality Weekly Report Vol 73 No 2 January 18 2024
    MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 2, January 18, 2024
    Centers for Disease Control and Prevention (U.S.)
    01/18/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Cannabis Use Among Students in Grades 8, 10, and 12, by Sex — King County, Washington, 2008–2021 / Precious Esie; Myduc TaPseudomonas Infection Outbreak Associated with a Hotel Swimming Pool — Maine, March 2023 / Liz Lamere; Emer Smith; Heather Grieser2 et al.Detecting Mpox Cases Through Wastewater Surveillance — United States, August 2022–May 2023 ...
    Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 73 No 1 January 11 2024
    MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 1, January 11, 2024
    Centers for Disease Control and Prevention (U.S.)
    01/11/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Topical Antifungal Prescribing for Medicare Part D Beneficiaries — United States, 2021 / Kaitlin Benedict; Dallas J. Smith; Tom Chiller et al.Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2024 / A. Patricia Wodi; Neil Murthy; Veronica V. McNally ...
    Public Domain
  • Supplementary Table 2 Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against Allcause Thromboembolic Events Among Immunocompetent Medicare Beneficiaries Aged 65 Years and Beneficiaries Aged 18 Years with End Stage Renal Disease Receiving Dialysis Without Additional Immunocompromising Conditions by Age Group and Time Since Vaccination United States September 2022March 2023
    Supplementary Table 2. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against All-cause Thromboembolic Events Among Immunocompetent Medicare Beneficiaries Aged ≥65 Years and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis Without Additional Immunocompromising Conditions, by Age Group and Time Since Vaccination — United States, September 2022–March 2023
    January 11, 2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Notice to Readers Change in Publication Date of MMWR Series
    Notice to Readers: Change in Publication Date of MMWR Series
    Centers for Disease Control and Prevention (U.S.)
    01/11/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Supplementary Table 1 Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against COVID19related Thromboembolic Events Among Medicare Beneficiaries Aged 65 Years with Immunocompromise and Beneficiaries Aged 18 Years with End Stage Renal Disease Receiving Dialysis with Immunocompromise by Age Group and Time Since Vaccination United States September 2022March 2023
    Supplementary Table 1. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against COVID-19-related Thromboembolic Events Among Medicare Beneficiaries Aged ≥65 Years with Immunocompromise and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis with Immunocompromise, by Age Group and Time Since Vaccination — United States, September 2022–March 2023
    January 11, 2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Table Influenza Updated COVID19 and RSV Vaccination Status and Intent for Vaccination Among Adults by Demographic Characteristics National Immunization SurveyAdult COVID Module United States December 39 2023
    Supplementary Table. Influenza, Updated COVID-19, and RSV Vaccination Status and Intent for Vaccination Among Adults by Demographic Characteristics, National Immunization Survey-Adult COVID Module, United States, December 3–9, 2023
    Centers for Disease Control and Prevention (U.S.)
    12/22/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 72 No 51 December 22 2023
    MMWR. Morbidity and Mortality Weekly Report, Vol. 72, No. 51, December 22, 2023
    Centers for Disease Control and Prevention (U.S.)
    12/22/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals / Dallas J. Smith; Anastasia Lambrou; Pragna Patel -- Evaluation of SARS-CoV-2 RNA Rebound After Nirmatrelvir/Ritonavir Treatment in Randomized, Double-Blind, Placebo-Controlled Trials — United States and International Sites, 2021–2022 / Patrick R. Harrington; Jie Cong; Stephanie B ...
    Public Domain
  • Supplementary Figure Viral RNA Shedding Levels for Individual Subjects With Viral RNA Rebound Among Subjects in the EPICHR Trial Who Met the Definitions of Posttreatment Viral RNA Rebound on Day 10 a or 14 B Those Who Met the Definition of Viral RNA Rebound During the Treatment Period From Day 3 to Day 5 C D Those in the EPICSR 2021PreOmicron E and 2022Omicron Enrollment Periods F Who Met the Definition of Day 10 or Day 14 Viral RNA Rebound
    Supplementary Figure. Viral RNA Shedding Levels for Individual Subjects With Viral RNA Rebound Among Subjects in the EPIC-HR Trial Who Met the Definitions of Posttreatment Viral RNA Rebound on Day 10 (a) or 14 (B); Those Who Met the Definition of Viral RNA Rebound During the Treatment Period From Day 3 to Day 5* (C, D); Those in the EPIC-SR 2021/Pre-Omicron (E) and 2022/Omicron Enrollment Periods (F), Who Met the Definition of Day 10 or Day 14 Viral RNA Rebound
    Centers for Disease Control and Prevention (U.S.)
    12/22/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • SARSCoV2 Rebound with and Without Use of COVID19 Oral Antivirals
    SARS-CoV-2 Rebound with and Without Use of COVID-19 Oral Antivirals
    Centers for Disease Control and Prevention (U.S.)
    12/22/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Table Baseline Demographic and Disease Characteristics of Evaluation of Protease Inhibition for COVID19 in HighRisk Patients EPICHR and Evaluation of Protease Inhibition for COVID19 in StandardRisk Patients EPICSR Study Participants United States and International Sites 20212022
    Supplementary Table. Baseline Demographic and Disease Characteristics of Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients (EPIC-HR) and Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR) Study Participants — United States and International Sites, 2021–2022
    Centers for Disease Control and Prevention (U.S.)
    12/22/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • MMWR week log 20232024
    MMWR week log (2023-2024)
    Centers for Disease Control and Prevention (U.S.)
    Dec. 21, 2023 | MMWR weeks
    Publication date from document properties.MMWR-Week-Log-2023-2024.pdf
    Public Domain
  • MMWR week log 20222023
    MMWR week log (2022-2023)
    Centers for Disease Control and Prevention (U.S.)
    Dec. 21, 2023 | MMWR weeks
    The MMWR week is the week of the epidemiologic year for which the National Notifiable Diseases Surveillance System (NNDSS) disease report is assigned by the reporting local or state health department for the purposes of MMWR disease incidence reporting and publishing. Values for MMWR week range from 1 to 53, although most years consist of 52 weeks. ...
    Public Domain
  • Suicide Rates by Industry and Occupation National Vital Statistics System United States 2021 Supplementary Table 1 Suicide Rates by Sex for Major and Detailed Industry Groups National Vital Statistics System United States 2021
    Suicide Rates by Industry and Occupation — National Vital Statistics System, United States, 2021: Supplementary Table 1. Suicide Rates, by Sex, for Major and Detailed Industry Groups — National Vital Statistics System, United States, 2021
    Centers for Disease Control and Prevention (U.S.)
    December 15, 2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Supplementary table for Li, Jia et al. (2023). Suicide Rates by Industry and Occupation – National Vital Statistics System, United States, 2021. 72(50).
    Public Domain
  • Supplementary Table 2 Suicide Rates by Sex for Major and Detailed Industry Groups National Vital Statistics System United States 2021
    Supplementary Table 2. Suicide Rates, by Sex, for Major and Detailed Industry Groups — National Vital Statistics System, United States, 2021
    Centers for Disease Control and Prevention (U.S.)
    12/15/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 72 No 50 December 15 2023
    MMWR. Morbidity and Mortality Weekly Report, Vol. 72, No. 50, December 15, 2023
    Centers for Disease Control and Prevention (U.S.)
    12/15/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Unintentional Firearm Injury Deaths Among Children and Adolescents Aged 0–17 Years — National Violent Death Reporting System, United States, 2003–2021 /Rebecca F. Wilson; Sasha Mintz; Janet M. Blair et al. -- Suicide Rates by Industry and Occupation — National Vital Statistics System, United States, 2021 / Aaron Sussell; Cora Peterson; Jia Li3 et a ...
    Public Domain
  • Suicide Rates by Industry and Occupation National Vital Statistics System United States 2021
    Suicide Rates by Industry and Occupation – National Vital Statistics System, United States, 2021
    Sussell, Aaron L. ;
    Peterson, Cora
    2023/12/15 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? The 2021 suicide rate among U.S. persons of working age is approximately 33% higher than it was 2 decades ago. What is added by this report? Data from 49 states were used to calculate suicide rates by sex for all major and detailed industry and occupational groups. Major industry groups with the highest suici ...
    Public Domain
  • Supplementary Figure 2 Sources of Data for Adverse Events Following Immunization Reported on the World Health OrganizationUNICEF Joint Reporting Form by World Health Organization Member States and Territories Worldwide 2022
    Supplementary Figure 2. Sources of Data for Adverse Events Following Immunization Reported on the World Health Organization/UNICEF Joint Reporting Form, by World Health Organization Member States and Territories — Worldwide, 2022
    Centers for Disease Control and Prevention (U.S.)
    12/08/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Supplementary Figure 1 Serious Adverse Events Following Immunization per Million Total Population Reported to VigiBase by Country Worldwide 2020 a 2021 B and 2022
    Supplementary Figure 1. Serious Adverse Events Following Immunization per Million Total Population Reported to VigiBase, by Country — Worldwide, 2020 (a), 2021 (B), and 2022 ©
    Centers for Disease Control and Prevention (U.S.)
    12/08/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 72 No 49 December 8 2023
    MMWR. Morbidity and Mortality Weekly Report, Vol. 72, No. 49, December 8, 2023
    Centers for Disease Control and Prevention (U.S.)
    12/08/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Large Community Outbreak of Legionnaires Disease Potentially Associated with a Cooling Tower — Napa County, California, 2022 /Nárjara V. Grossmann; Crystal Milne; Melinda R. Martinez et al. -- "Progress in Immunization Safety Monitoring — Worldwide, 2020–2022 / Erin F. Blau; Madhava Ram Balakrishnan; Helena Sköld et al. -- Use of Inactivated Polio ...
    Public Domain
  • Supplementary Figure Single Nucleotide Polymorphism Phylogenetic Tree of Clinical Specimens and Environmental Samples That Tested Positive for Legionella pneumophila Type 1 Napa County California 2022
    Supplementary Figure. Single Nucleotide Polymorphism Phylogenetic Tree of Clinical Specimens and Environmental Samples That Tested Positive for Legionella pneumophila Type 1 — Napa County, California, 2022
    Centers for Disease Control and Prevention (U.S.)
    12/08/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
261 - 280 / 9447